Literature DB >> 1346421

Primary prevention of stroke.

M G Marmot1, N R Poulter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346421     DOI: 10.1016/0140-6736(92)91659-v

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

Review 1.  Selective versus nonselective beta adrenoceptor antagonists in hypertension.

Authors:  L M Van Bortel; A J Ament
Journal:  Pharmacoeconomics       Date:  1995-12       Impact factor: 4.981

Review 2.  Management of lipid disorders in the elderly.

Authors:  D A Playford; G F Watts
Journal:  Drugs Aging       Date:  1997-06       Impact factor: 3.923

Review 3.  Prophylaxis and treatment of stroke. The state of the art in 1993.

Authors:  C A Sila
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

Review 4.  Epidemiology of stroke.

Authors:  K T Khaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

5.  Stroke risk among Chinese immigrants in New York City.

Authors:  Jing Fang; Sun Hoo Foo; Cora Fung; Judith Wylie-Rosett; Michael H Alderman
Journal:  J Immigr Minor Health       Date:  2006-10

6.  Clinical profile of stroke:: The experience at King Abdulaziz University Hospital.

Authors:  Daad H Akbar; Maimona Mushtaq
Journal:  J Sci Res Med Sci       Date:  2001-04

7.  Management of hypertension in the elderly: attitudes of general practitioners and hospital physicians.

Authors:  G A Ford; M N Asghar
Journal:  Br J Clin Pharmacol       Date:  1995-05       Impact factor: 4.335

8.  Treating hypertension after stroke.

Authors:  J E O'Connell; C Gray
Journal:  BMJ       Date:  1994-06-11

9.  Trends in mortality from major diseases in Europe, 1980-1993.

Authors:  C La Vecchia; F Levi; F Lucchini; E Negri
Journal:  Eur J Epidemiol       Date:  1998-01       Impact factor: 8.082

Review 10.  Headache and the risk of stroke.

Authors:  Pekka Jousilahti
Journal:  Curr Atheroscler Rep       Date:  2004-07       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.